Status:
COMPLETED
Early Cognitive Impairment in Multiple Sclerosis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
ARSEP (Association pour la Recherche sur la Sclerose en Plaques)
JNLF (Journées de Neurologie de Langue Française)
Conditions:
Multiple Sclerosis
Cognitive Impairment
Eligibility:
All Genders
18-40 years
Brief Summary
Cognitive impairment is one of the symptoms of Multiple Sclerosis (MS), and it may occur during the first years of the disease. It usually affects attention, information processing speed and short ter...
Detailed Description
Cognitive impairment in Multiple Sclerosis (MS) occurs in 50% of patients and has a major social impact. There is no clear correlation between cognitive dysfunction and disease duration and recent stu...
Eligibility Criteria
Inclusion
- Relapsing remitting Multiple Sclerosis patients
- Age: 18-40 years
- Evolving between 3 and 5 years
- EDSS\<5
Exclusion
- MRI exclusion criteria (metallic prothetic, pace maker etc)
- Renal failure due to Gadolinium injection
- Major depressive disorder
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT01157728
Start Date
May 1 2008
End Date
December 1 2010
Last Update
July 31 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pitie salpêtrière Hospital
Paris, France, 75013